skip to content
home ver. 2.3. site index contact us
Schering-Plough
About Us Products and Care R&D Partnerships News and Media Investor Relations Corporate Responsibility Careers
Diseases & Conditions
Allergy & Respiratory
Animal Health
Anti-Infectives
Arthritis & Immunology
Cancer Therapies
Cholesterol-Lowering / Cardiovascular
Erectile Dysfunction
Foot Care
Hepatitis
Skin Disorders & Sun Care
Other
A-Z Product Listing
Patient Assistance and Support Programs

Patient Assistance and Support Programs

Commitment to Care Schering-Plough Cares

Schering-Plough is committed to improving the health and well-being of people throughout the world. In fulfilling that commitment, we are developing new treatments and programs that assist patients in achieving their best possible therapeutic outcomes. In the United States, an important part of this effort involves helping patients through our patient assistance and patient support programs.

Schering-Plough believes that the pharmaceutical industry needs to address the challenges facing low-income, chronically ill, underinsured and/or other uninsured people who cannot access the prescription medicines they need to improve their health. We support efforts to increase access, and are committed to assisting patients in need to obtain treatment. We continuously evaluate our patient assistance programs for their ability to do the most good for the most people. We intend to maintain and, to the extent financially prudent, expand our programs.

Patient Assistance
Schering-Plough assists patients in securing drug reimbursement as well as providing lifesaving drugs at no cost to people with low incomes through our patient assistance programs.

Informal patient assistance programs have been in place at Schering-Plough since the early 1980s. Today, patients can apply for assistance through two programs: Commitment to Care (1-800-521-7157), which covers our cancer, hepatitis and anti-fungal drugs; and Schering-Plough Cares (1-800-656-9485), which includes most of our other prescription drugs. In 2007, these programs provided more than 60,000 patients with over $100 million worth of free Schering-Plough products.

Patient Support
Be In Charge is a free patient support program designed to provide education and support to people diagnosed with hepatitis B or C who are either not yet on therapy or who are receiving Schering-Plough's PEGINTRON (peginterferon alfa-2b) Powder for Injection or INTRON A (interferon alfa-2b, recombinant) for Injection therapy.

People enrolling in Be In Charge benefit by having access to specially trained nurses and educational materials to help them understand their condition and its therapy. If participants choose, a personal nurse counselor will be assigned to them who will call them periodically to answer their questions and encourage them throughout their therapy. Participants who wish will also receive educational materials with tips to help them remain on therapy. Be In Charge has helped thousands of people since its inception.

To find out more about Be In Charge, call toll free: 1-888-437-2608.

All of Schering-Plough's patient assistance and support programs are administered on behalf of the company by outside organizations. Patient eligibility for Commitment to Care and Schering-Plough Cares are determined case by case based on financial and insurance criteria. Schering-Plough reviews its patient assistance and support programs periodically to ensure that they are meeting the needs of both patients and the physicians who treat them.

Click here for more information on NASONEX

HomeAbout UsProducts & CareR&DPartnerships
News & MediaInvestor RelationsCorporate ResponsibilityCareers
Contact Us Site Index
© 2003 - 2008 Schering-Plough Corporation.
Please see our legal notice, privacy policy and forward-looking statement.
Schering-Plough Schering-Plough skip to content Schering-Plough